Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer. Wang QY, Benzerdjeb N, Jaquet S, Stepanov A, et al. Hum Pathol 2025;163:105877.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang QY, Benzerdjeb N, Jaquet S, Stepanov A, et al. Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer. Hum Pathol 2025;163:105877.
PMID: 40714131